Avantor : 2026 Q1 Earnings Presentation
AVTR
Published on 04/29/2026 at 09:20 am EDT
Earnings Presentation
April 29, 2026
Q1 results exceeded expectations
Revival is already having a positive impact
Improved execution and performance
Engaged and motivated team
We believe that we are turning a corner financially
Evolve go to market strategy
Strategically invest in our manufacturing
and supply chain organization
Optimize our portfolio
Simplify how we work
Strengthen our talent and improve accountability
~25% of our ~60 leaders have been refreshed since launch of Revival
More high-impact leaders to come
Self-funded with productivity; year to date headcount -2%
Chief Operating Officer
Chief Transformation Officer
Chief Procurement Officer
Chief Digital Officer
Head of BMP
Head of VWR Sourcing
Head of VWR Pricing
GM Bioscience Chemicals
Note: Leadership team defined as direct reports to Emmanuel Ligner plus their direct reports.
Strengthen our talent and improve accountability
~25% Refresh
Top ~60
Leaders
Strategically invest
in our manufacturing and supply chain organization
8 weeks of Kaizen events in Q1
Capex Council established
Data-driven analysis
12 capex projects sanctioned
Decrease cycle time per unit from >250 seconds to <30 seconds
>35% increase in process capacity
>50% decrease in operator requirements
Enhanced quality and compliance
OP OP OP
30 40 50
Highly attractive returns on capital
OP 10
Out
In OP
OP 70
OP 60
20
Q1'26
Q1'25
$1,581M
$1,581M
-4%
-2%
$501M
$535M
31.7%
33.8%
$219M
$270M
13.9%
17.0%
$191M
$243M
12.1%
15.4%
$0.17
$0.23
$25M
$82M
3.3x
3.2x
Organic growth
% of revenues
% of revenues
% of revenues
Free cash flow includes cash restructuring costs of $14M and $6M in Q1'26 and Q1'25, respectively, and transformation costs of $13M in Q1'25.
Reflects adjusted net leverage as of the final day of the quarter.
VWR Distribution & Services Bioscience & Medtech Products
Reported
Revenue
$1,150M
Organic
Adjusted
Operating income
$105M
Adj.
Reported
Revenue
$431M
Organic
Adjusted
Operating income
$103M
Adj.
Growth: -5%
Operating Margin:
9.2%
Growth: -2%
Operating Margin:
23.8%
Note: Page does not include "Corporate" Adjusted Operating Income of ($18M) in Q1'26.
Guidance Metrics
Organic revenue growth -2.5% to -0.5%
Adj. EBITDA margin 14.8% to 15.3%
Adj. EPS $0.77 to $0.83
Free cash flow2 $500M to $550M
Reported revenue range is -1.5% to 0.5%, reflecting 1% FX tailwinds. (FY blended USD / EUR exchange rate of 1.17).
Excludes cash restructuring costs.
Q1 results exceeded expectations
Revival is already having a positive impact
Improved execution and performance
Engaged and motivated team
We believe that we are turning a corner financially
Powering science at .
Disclaimer
Avantor Inc. published this content on April 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 29, 2026 at 13:19 UTC.